SEC Form 4 insider trading filings tracked in real time from EDGAR

Davidson Matt — Chief Development Officer

Insider trading activity for Davidson Matt sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Development Officer
  • Company: ADIAL PHARMACEUTICALS, INC.
  • Total insider trades: 6
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: Jun 16, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Jun 12, 2026 Davidson Matt ADIL ADIAL PHARMACEUTICALS, INC. BUY 232,417 N/A
Jun 11, 2026 Davidson Matt ADIL ADIAL PHARMACEUTICALS, INC. BUY 101.298 N/A
Jun 11, 2026 Davidson Matt ADIL ADIAL PHARMACEUTICALS, INC. BUY 1,822.13 N/A
Jun 12, 2026 Davidson Matt ADIL ADIAL PHARMACEUTICALS, INC. BUY 232,417 N/A
Jun 11, 2026 Davidson Matt ADIL ADIAL PHARMACEUTICALS, INC. BUY 3,427 N/A
Jun 11, 2026 Davidson Matt ADIL ADIAL PHARMACEUTICALS, INC. BUY 61,647 N/A

← All executives · Full trades feed